All News

In this interview, Gerald H. Jordan, MD, executive secretary of the American Board of Urology, discusses various aspects of certification, including the meaning of board eligibility, why the written exam is so difficult, the future of the oral exam, and which urologists are required to undergo maintenance of certification.

Some of the urologists interviewed had not noticed any effect from the ACA, although another said he has seen fewer younger patients.

A report analyzing more than 191,000 cases of prostate cancer has found that being overweight or obese increases men’s risk for advanced prostate cancer.

Testosterone replacement therapy reduced men’s overall risks for death, nonfatal myocardial infarction, and stroke, as well as for death alone in a study presented at the American Heart Association Scientific Sessions in Chicago.

The 529 plan allows you to remove wealth from your estate while you steadily accumulate assets to help educate children, grandchildren, nieces, nephews, and even yourself, if you're planning to go back to college.

In this article, Ray Painter, MD, and Mark Painter provide some facts about the 2015 Medicare fee schedule and share some insights on how its changes will impact your practice in the New Year.

The claim alleged negligence in injuring the right ureter with a retractor during the original operation, and also claimed that the physicians were negligent in opening the bladder when removing part of the left ureter without performing a biopsy first.

Autologous pubovaginal slings are associated with a high success rate following synthetic midurethral sling failure, according to recently published data.

Results from the U.S. validation study of a test that combines plasma levels of four prostate-specific kallikreins with clinical data demonstrated it accurately predicts high-grade prostate cancer and is superior to a validated clinical variable-based risk calculator.

Blue light cystoscopy with hexaminolevulinate HCl (HAL-BLC) should be considered for initial diagnosis of nonmuscle-invasive bladder cancer, an expert panel of urologists recently concluded.

Survivors of bladder, kidney, and two other forms of cancer who smoked 20 or more cigarettes a day prior to their cancer diagnoses have an up to fivefold higher risk of developing a second smoking-associated cancer compared to survivors of the same cancers who never smoked.

Even with the GOP more firmly entrenched on Capitol Hill, a permanent fix of the sustainable growth rate formula is still a possibility, say urologist James Ulchaker, MD, and Brad Stine of the AUA.

A personalized genetic test has been shown to predict risk of prostate cancer recurrence following radical prostatectomy or radiotherapy, according to a recent study.

Dendreon Corp., the maker of sipuleucel-T (Provenge), said it expects no impact on access to the prostate cancer immunotherapy following the company’s Chapter 11 filing last week.

This video demonstrates a wide-excision prostatectomy for patients with locally advanced, high-risk prostate cancer.

These videos depict a classic tennis racquet bladder neck reconstruction and mucosal eversion as popularized by Patrick Walsh, MD, for open prostatectomy, but used by relatively few surgeons for robotic prostatectomy.

The AUA has refuted findings from a recent study that reported a modest association between vasectomy and lethal prostate cancer.

Individuals with a history of kidney stones should increase their fluid intake to achieve at least 2 liters of urine per day to prevent recurrence, and if this fails, treatment with a thiazide diuretic, citrate, or allopurinol is recommended, according to a new clinical practice guideline from the American College of Physicians.

The Centers for Medicare & Medicaid Services has approved two new Category I CPT codes for the UroLift system, a treatment for BPH, effective Jan. 1, 2015.

Other products featured include a 16-slice CT scanner, new generic testosterone gel, prostate cancer risk calculator, and more.

LUGPA 2014, Annual Meeting, November 6-8 / Chicago

Here is a collection of ICD-10 resources for urologists, including a checklist and links to articles, FAQs, and more.

For physicians who have small practices and might still be struggling with EMRs and other government regulations, ICD-10 implementation could be the last straw, says W. Jeff Terry, Sr., MD. Here are some possible fixes suggested by Dr. Terry.

Mark Painter, CEO of PRS Urology, and Jonathan Rubenstein, MD, a urologist in Baltimore and member of the AUA’s Coding and Reimbursement Committee, recommend this checklist for ICD-10 urology practice transition.

Whatever the exact mechanism of the increase in desire for testosterone replacement therapy in men, knowing the risks and benefits of testosterone and its alternatives are vital skills for today’s practicing urologist. This article will focus on alternatives to testosterone therapy.

As the health care market matures, consolidation will occur throughout the system, including within medical groups, says Steven M. Berkowitz, MD.

As owner and president of Shift Happens, a Chicago-based consulting firm, James Feldman is not a physician. But he learned some valuable, if not difficult, lessons about practicing medicine from his physician father.

New biomarkers for prostate cancer are showing great promise for addressing the limitations of existing diagnostic and prognostic tools, according to opinion leaders who spoke on this topic at the Large Urology Group Practice Association annual meeting in Chicago.

There has been and remains a shortage of urologists in the United States that is expected to worsen, and experts inside and outside of urology generally agree that physician assistants (PAs) will be called upon increasingly to help shoulder the burden of a declining work force. The remaining question-and a frequently contentious one-is, what specific tasks should these men and women be allowed to carry out.

Magnetic resonance imaging (MRI) is a promising tool for optimizing prostate cancer biopsy that appears to overcome the shortcomings of conventional systematic transrectal ultrasound (TRUS)-guided biopsy and also provides novel information for risk stratification that can guide the decision of whether to perform biopsy, according to Samir Taneja, MD.